Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
According to our market capitalization data, Eli Lilly (LLY) reached a market cap of $754.27 billion, securing the top spot among global Biotech companies. Johnson & Johnson (JNJ) and AbbVie (ABBV) follow closely behind. The data was last updated on April 18, 2025.
| Rank | Name | Market Cap | Price | MCap(30D) | MCap(1Y) | Country |
|---|---|---|---|---|---|---|
|
201
|
 Janux Therapeutics
JANX
|
$1.75 B | $29.69 |
0.00%
|
-22.4%
|
United States
|
|
202
|
 Natco Pharma
NATCOPHARM.NS
|
$1.74 B | $9.69 |
0.00%
|
25.3%
|
India
|
|
203
|
 Supernus Pharmaceuticals
SUPN
|
$1.72 B | $30.76 |
0.00%
|
29.0%
|
United States
|
|
204
|
 Nippon Shinyaku
4516.T
|
$1.72 B | $25.48 |
0.00%
|
-9.6%
|
Japan
|
|
205
|
 Novocure
NVCR
|
$1.71 B | $15.58 |
0.00%
|
85.9%
|
|
|
206
|
 Jubilant Pharmova
JUBLPHARMA.NS
|
$1.70 B | $10.76 |
0.00%
|
42.1%
|
India
|
|
207
|
 PeptiDream
4587.T
|
$1.71 B | $13.16 |
0.00%
|
42.2%
|
Japan
|
|
208
|
 Beam Therapeutics
BEAM
|
$1.70 B | $17.00 |
0.00%
|
11.2%
|
United States
|
|
209
|
 Kymera Therapeutics
KYMR
|
$1.69 B | $25.97 |
0.00%
|
6.1%
|
United States
|
|
210
|
 Centessa Pharmaceuticals
CNTA
|
$1.64 B | $12.30 |
0.00%
|
52.3%
|
United Kingdom
|
|
211
|
 Biotest
BIO.F
|
$1.64 B | $47.86 |
0.00%
|
-2.4%
|
Germany
|
|
212
|
 Harmony Biosciences
HRMY
|
$1.63 B | $28.46 |
0.00%
|
29.2%
|
United States
|
|
213
|
 Galapagos NV
GLPG
|
$1.63 B | $24.66 |
0.00%
|
-12.5%
|
Belgium
|
|
214
|
 Taro Pharmaceutical
TARO
|
$1.62 B | $42.97 |
0.00%
|
1.7%
|
Israel
|
|
215
|
 Fagron
FAGR.BR
|
$1.61 B | $21.99 |
0.00%
|
13.9%
|
Belgium
|
|
216
|
 Agios Pharmaceuticals
AGIO
|
$1.58 B | $27.66 |
0.00%
|
15.0%
|
United States
|
|
217
|
 CG Oncology
CGON
|
$1.57 B | $20.64 |
0.00%
|
-20.0%
|
United States
|
|
218
|
 BioCryst Pharmaceuticals
BCRX
|
$1.55 B | $7.40 |
0.00%
|
94.8%
|
United States
|
|
219
|
 Arcutis Biotherapeutics
ARQT
|
$1.54 B | $13.01 |
0.00%
|
27.4%
|
United States
|
|
220
|
 Arrowhead Pharmaceuticals
ARWR
|
$1.54 B | $11.24 |
0.00%
|
-10.8%
|
United States
|
|
221
|
 IDEAYA Biosciences
IDYA
|
$1.50 B | $17.08 |
0.00%
|
-39.6%
|
United States
|
|
222
|
 HBM Healthcare Investments
HBMN.SW
|
$1.48 B | $218.98 |
0.00%
|
4.6%
|
Switzerland
|
|
223
|
 Pharma Mar
PHM.MC
|
$1.48 B | $85.41 |
0.00%
|
285.2%
|
Spain
|
|
224
|
 Kiniksa Pharmaceuticals
KNSA
|
$1.47 B | $20.21 |
0.00%
|
16.7%
|
|
|
225
|
 ARS Pharmaceuticals
SPRY
|
$1.46 B | $14.88 |
0.00%
|
38.6%
|
United States
|
|
226
|
 Disc Medicine
IRON
|
$1.46 B | $42.17 |
0.00%
|
90.7%
|
United States
|
|
227
|
 Genus
GNS.L
|
$1.41 B | $2151.42 |
0.00%
|
-16.6%
|
United Kingdom
|
|
228
|
 Immunocore
IMCR
|
$1.40 B | $28.41 |
0.00%
|
-48.7%
|
United Kingdom
|
|
229
|
 MannKind Corp
MNKD
|
$1.38 B | $4.54 |
0.00%
|
33.7%
|
United States
|
|
230
|
 Faes Farma
FAE.MC
|
$1.37 B | $4.42 |
0.00%
|
21.2%
|
Spain
|
|
231
|
 Mesoblast
MESO
|
$1.36 B | $10.72 |
0.00%
|
243.6%
|
Australia
|
|
232
|
 Vera Therapeutics
VERA
|
$1.36 B | $21.29 |
0.00%
|
-5.6%
|
United States
|
|
233
|
 Granules India
GRANULES.NS
|
$1.33 B | $5.47 |
0.00%
|
41.3%
|
India
|
|
234
|
 Travere Therapeutics
TVTX
|
$1.32 B | $14.92 |
0.00%
|
268.9%
|
United States
|
|
235
|
 Dynavax Technologies
DVAX
|
$1.28 B | $10.31 |
0.00%
|
11.9%
|
United States
|
|
236
|
 Evotec
EVO
|
$1.28 B | $3.60 |
0.00%
|
-35.2%
|
Germany
|
|
237
|
 ChemoMetec
CHEMM.CO
|
$1.27 B | $73.20 |
0.00%
|
106.9%
|
Denmark
|
|
238
|
 Structure Therapeutics
GPCR
|
$1.25 B | $21.76 |
0.00%
|
-33.2%
|
United States
|
|
239
|
 NeoGenomics
NEO
|
$1.23 B | $9.55 |
0.00%
|
-0.15%
|
United States
|
|
240
|
 Integra LifeSciences
IART
|
$1.22 B | $15.83 |
0.00%
|
-10.8%
|
United States
|
|
241
|
 Celldex Therapeutics
CLDX
|
$1.21 B | $18.30 |
0.00%
|
-43.3%
|
United States
|
|
242
|
 Liquidia Technologies
LQDA
|
$1.17 B | $13.72 |
0.00%
|
22.0%
|
United States
|
|
243
|
 Ocular Therapeutix
OCUL
|
$1.16 B | $7.31 |
0.00%
|
41.6%
|
United States
|
|
244
|
 Azenta
AZTA
|
$1.15 B | $25.25 |
0.00%
|
-6.2%
|
United States
|
|
245
|
 Ardelyx
ARDX
|
$1.15 B | $4.82 |
0.00%
|
-14.0%
|
United States
|
|
246
|
 Innoviva
INVA
|
$1.15 B | $18.27 |
0.00%
|
21.7%
|
United States
|
|
247
|
 Pacira Biosciences
PCRX
|
$1.14 B | $24.65 |
0.00%
|
-0.57%
|
United States
|
|
248
|
 Indivior PLC
INDV
|
$1.13 B | $9.01 |
0.00%
|
-48.5%
|
United States
|
|
249
|
 Amphastar Pharmaceuticals
AMPH
|
$1.11 B | $23.35 |
0.00%
|
-19.5%
|
United States
|
|
250
|
 Calliditas Therapeutics
CALT
|
$1.10 B | $40.00 |
0.00%
|
113.9%
|
Sweden
|
|
251
|
 Adaptive Biotechnologies
ADPT
|
$1.09 B | $7.33 |
0.00%
|
220.0%
|
United States
|
|
252
|
 Viridian Therapeutics
VRDN
|
$1.07 B | $13.13 |
0.00%
|
23.2%
|
United States
|
|
253
|
 Aurinia Pharmaceuticals
AUPH
|
$1.06 B | $7.75 |
0.00%
|
56.1%
|
Canada
|
|
254
|
 Biolife Solutions
BLFS
|
$1.04 B | $21.91 |
0.00%
|
63.4%
|
United States
|
|
255
|
 Molinos Agro S.A.
MOLA.BA
|
$1.04 B | $21.19 |
0.00%
|
52.4%
|
Argentina
|
|
256
|
 Vetoquinol
VETO.PA
|
$1.04 B | $87.52 |
0.00%
|
-22.8%
|
France
|
|
257
|
 Iovance Biotherapeutics
IOVA
|
$1.00 B | $3.06 |
0.00%
|
-53.0%
|
United States
|
|
258
|
 Syndax Pharmaceuticals
SNDX
|
$0.99 B | $11.54 |
0.00%
|
-27.3%
|
United States
|
|
259
|
 MiMedx Group
MDXG
|
$0.98 B | $6.68 |
0.00%
|
32.8%
|
United States
|
|
260
|
 Artivion
AORT
|
$0.98 B | $22.93 |
0.00%
|
52.4%
|
United States
|
|
261
|
 Novavax
NVAX
|
$0.97 B | $6.00 |
0.00%
|
106.3%
|
United States
|
|
262
|
 Cosmo Pharmaceuticals
C43.F
|
$0.93 B | $56.98 |
0.00%
|
-6.1%
|
Ireland
|
|
263
|
 Dyne Therapeutics
DYN
|
$0.93 B | $8.17 |
0.00%
|
-39.3%
|
United States
|
|
264
|
 Poseida Therapeutics
PSTX
|
$0.93 B | $9.50 |
0.00%
|
370.3%
|
United States
|
|
265
|
 10x Genomics
TXG
|
$0.92 B | $7.51 |
0.00%
|
-56.8%
|
United States
|
|
266
|
 Wave Life Sciences
WVE
|
$0.91 B | $5.92 |
0.00%
|
122.0%
|
Singapore
|
|
267
|
 Gubra A/S
GUBRA.CO
|
$0.89 B | $54.36 |
0.00%
|
135.3%
|
Denmark
|
|
268
|
 89bio
ETNB
|
$0.88 B | $6.06 |
0.00%
|
20.9%
|
United States
|
|
269
|
 Oculis Holding AG
OCS
|
$0.88 B | $18.27 |
0.00%
|
83.3%
|
Switzerland
|
|
270
|
 Collegium Pharmaceutical
COLL
|
$0.87 B | $27.01 |
0.00%
|
-12.4%
|
United States
|
|
271
|
 Mineralys Therapeutics
MLYS
|
$0.87 B | $13.35 |
0.00%
|
-15.8%
|
United States
|
|
272
|
 Harrow Health
HROW
|
$0.86 B | $23.99 |
0.00%
|
206.2%
|
United States
|
|
273
|
 Arcus Biosciences
RCUS
|
$0.83 B | $7.88 |
0.00%
|
-14.7%
|
United States
|
|
274
|
 Gyre Therapeutics
GYRE
|
$0.83 B | $8.88 |
0.00%
|
-23.2%
|
United States
|
|
275
|
 FDC India
FDC.NS
|
$0.82 B | $5.04 |
0.00%
|
7.9%
|
India
|
|
276
|
 BML, Inc.
4694.T
|
$0.81 B | $20.89 |
0.00%
|
-5.3%
|
Japan
|
|
277
|
 Enliven Therapeutics
ELVN
|
$0.81 B | $16.53 |
0.00%
|
24.7%
|
United States
|
|
278
|
 Geron
GERN
|
$0.81 B | $1.27 |
0.00%
|
-23.6%
|
United States
|
|
279
|
 Zymeworks
ZYME
|
$0.80 B | $11.53 |
0.00%
|
69.6%
|
Canada
|
|
280
|
 Chimerix
CMRX
|
$0.80 B | $8.54 |
0.00%
|
361.4%
|
United States
|
|
281
|
 Avid Bioservices
CDMO
|
$0.80 B | $12.49 |
0.00%
|
95.5%
|
United States
|
|
282
|
 Nurix Therapeutics
NRIX
|
$0.78 B | $10.24 |
0.00%
|
32.5%
|
United States
|
|
283
|
 Avadel Pharmaceuticals
AVDL
|
$0.78 B | $8.03 |
0.00%
|
-50.3%
|
Ireland
|
|
284
|
 SPIMACO (Saudi Pharmaceutical Industries and Medical Appliances Corporation)
2070.SR
|
$0.77 B | $6.59 |
0.00%
|
-17.9%
|
Saudi Arabia
|
|
285
|
 Spyre Therapeutics
SYRE
|
$0.76 B | $12.67 |
0.00%
|
-29.8%
|
United States
|
|
286
|
 Pharvaris
PHVS
|
$0.76 B | $14.00 |
0.00%
|
-9.9%
|
Netherlands
|
|
287
|
 Anavex Life Sciences
AVXL
|
$0.76 B | $8.95 |
0.00%
|
133.1%
|
United States
|
|
288
|
 SD BioSensor
137310.KS
|
$0.75 B | $6.30 |
0.00%
|
8.4%
|
South Korea
|
|
289
|
 Vir Biotechnology
VIR
|
$0.75 B | $5.50 |
0.00%
|
18.0%
|
United States
|
|
290
|
 Intellia Therapeutics
NTLA
|
$0.75 B | $7.23 |
0.00%
|
-55.6%
|
United States
|
|
291
|
 AbCellera
ABCL
|
$0.72 B | $2.42 |
0.00%
|
-15.5%
|
Canada
|
|
292
|
 Strides Pharma
STAR.NS
|
$0.70 B | $7.65 |
0.00%
|
-25.8%
|
India
|
|
293
|
 Myriad Genetics
MYGN
|
$0.70 B | $7.64 |
0.00%
|
-32.7%
|
United States
|
|
294
|
 uniQure
QURE
|
$0.70 B | $13.00 |
0.00%
|
203.6%
|
Netherlands
|
|
295
|
 Curevac
CVAC
|
$0.70 B | $3.12 |
0.00%
|
49.6%
|
Germany
|
|
296
|
 Day One Biopharmaceuticals
DAWN
|
$0.69 B | $6.84 |
0.00%
|
-20.7%
|
United States
|
|
297
|
 Axogen
AXGN
|
$0.69 B | $15.57 |
0.00%
|
172.6%
|
United States
|
|
298
|
 Immunome
IMNM
|
$0.69 B | $7.91 |
0.00%
|
-27.5%
|
United States
|
|
299
|
 Evolus
EOLS
|
$0.69 B | $10.79 |
0.00%
|
13.7%
|
United States
|
|
300
|
 Xencor
XNCR
|
$0.68 B | $9.70 |
0.00%
|
-8.4%
|
United States
|
|
301
|
 Praxis Precision Medicines
PRAX
|
$0.68 B | $33.79 |
0.00%
|
81.0%
|
United States
|
|
302
|
 Rocket Pharmaceuticals
RCKT
|
$0.67 B | $6.33 |
0.00%
|
-55.7%
|
United States
|
|
303
|
 PolyPeptide Group
PPGN.SW
|
$0.68 B | $20.48 |
0.00%
|
-18.2%
|
Switzerland
|
|
304
|
 Nuvation Bio
NUVB
|
$0.67 B | $1.97 |
0.00%
|
-12.3%
|
United States
|
|
305
|
 LENZ Therapeutics
LENZ
|
$0.66 B | $23.82 |
0.00%
|
56.1%
|
United States
|
|
306
|
 Exscientia
EXAI
|
$0.63 B | $4.84 |
0.00%
|
14.2%
|
United Kingdom
|
|
307
|
 Xeris Pharmaceuticals
XERS
|
$0.63 B | $4.11 |
0.00%
|
105.2%
|
United States
|
|
308
|
 AnaptysBio
ANAB
|
$0.63 B | $20.55 |
0.00%
|
-34.6%
|
United States
|
|
309
|
 Hikal
HIKAL.NS
|
$0.62 B | $5.05 |
0.00%
|
14.0%
|
India
|
|
310
|
 ArriVent BioPharma
AVBP
|
$0.62 B | $18.14 |
0.00%
|
73.6%
|
United States
|
|
311
|
 Replimune
REPL
|
$0.62 B | $7.99 |
0.00%
|
103.4%
|
United States
|
|
312
|
 ChromaDex
CDXC
|
$0.61 B | $7.52 |
0.00%
|
51.8%
|
United States
|
|
313
|
 Arbutus Biopharma
ABUS
|
$0.60 B | $3.15 |
0.00%
|
22.4%
|
United States
|
|
314
|
 KalVista Pharmaceuticals
KALV
|
$0.60 B | $12.00 |
0.00%
|
-20.6%
|
United States
|
|
315
|
 KYORIN Pharmaceutical
4569.T
|
$0.60 B | $10.38 |
0.00%
|
-18.6%
|
Japan
|
|
316
|
 Arvinas
ARVN
|
$0.59 B | $8.60 |
0.00%
|
-45.4%
|
United States
|
|
317
|
 SI-BONE
SIBN
|
$0.59 B | $13.85 |
0.00%
|
10.7%
|
United States
|
|
318
|
 Trevi Therapeutics
TRVI
|
$0.59 B | $6.07 |
0.00%
|
43.2%
|
United States
|
|
319
|
 Keros Therapeutics
KROS
|
$0.57 B | $14.07 |
0.00%
|
-82.0%
|
United States
|
|
320
|
 SPARC
SPARC.NS
|
$0.57 B | $1.76 |
0.00%
|
-43.1%
|
India
|
|
321
|
 Valneva SE
VALN
|
$0.57 B | $6.79 |
0.00%
|
-40.1%
|
France
|
|
322
|
 GH Research
GHRS
|
$0.56 B | $9.10 |
0.00%
|
29.7%
|
Ireland
|
|
323
|
 Pharming Group
PHAR
|
$0.55 B | $8.09 |
0.00%
|
-8.0%
|
Netherlands
|
|
324
|
 Fulgent Genetics
FLGT
|
$0.55 B | $17.86 |
0.00%
|
-20.6%
|
United States
|
|
325
|
 Akebia Therapeutics
AKBA
|
$0.54 B | $2.06 |
0.00%
|
54.4%
|
United States
|
|
326
|
 Organogenesis
ORGO
|
$0.54 B | $4.22 |
0.00%
|
23.1%
|
United States
|
|
327
|
 Opthea
OPT
|
$0.52 B | $3.41 |
0.00%
|
57.9%
|
Australia
|
|
328
|
 Savara Pharmaceuticals
SVRA
|
$0.52 B | $3.01 |
0.00%
|
-42.0%
|
United States
|
|
329
|
 Immatics
IMTX
|
$0.52 B | $4.26 |
0.00%
|
-50.5%
|
Germany
|
|
330
|
 Capricor Therapeutics
CAPR
|
$0.51 B | $11.25 |
0.00%
|
178.2%
|
United States
|
|
331
|
 Bicycle Therapeutics
BCYC
|
$0.51 B | $7.39 |
0.00%
|
-36.8%
|
United Kingdom
|
|
332
|
 Cogent Biosciences
COGT
|
$0.50 B | $4.37 |
0.00%
|
30.6%
|
United States
|
|
333
|
 Prothena
PRTA
|
$0.50 B | $9.20 |
0.00%
|
-33.0%
|
Ireland
|
|
334
|
 PolyNovo
PNV.AX
|
$0.49 B | $0.71 |
0.00%
|
-3.0%
|
Australia
|
|
335
|
 Boiron
BOI.PA
|
$0.48 B | $27.69 |
0.00%
|
-18.0%
|
France
|
|
336
|
 Kura Oncology
KURA
|
$0.48 B | $5.90 |
0.00%
|
-49.9%
|
United States
|
|
337
|
 Tyra Biosciences
TYRA
|
$0.47 B | $8.92 |
0.00%
|
-17.3%
|
United States
|
|
338
|
 Cullinan Therapeutics
CGEM
|
$0.46 B | $7.89 |
0.00%
|
-35.5%
|
United States
|
|
339
|
 Sage Therapeutics
SAGE
|
$0.46 B | $7.43 |
0.00%
|
-45.5%
|
United States
|
|
340
|
 Relay Therapeutics
RLAY
|
$0.46 B | $2.69 |
0.00%
|
-32.7%
|
United States
|
|
341
|
 Ginkgo Bioworks
DNA
|
$0.46 B | $7.85 |
0.00%
|
-60.9%
|
United States
|
|
342
|
 Maravai LifeSciences
MRVI
|
$0.45 B | $1.77 |
0.00%
|
-41.1%
|
United States
|
|
343
|
 Tilray
TLRY
|
$0.45 B | $0.45 |
0.00%
|
-46.2%
|
Canada
|
|
344
|
 UroGen Pharma
URGN
|
$0.45 B | $9.67 |
0.00%
|
-21.8%
|
United States
|
|
345
|
 Mind Medicine
MNMD
|
$0.43 B | $5.77 |
0.00%
|
-5.8%
|
United States
|
|
346
|
 Theravance Biopharma
TBPH
|
$0.43 B | $8.62 |
0.00%
|
2.9%
|
|
|
347
|
 SIGA Technologies
SIGA
|
$0.43 B | $5.99 |
0.00%
|
-27.2%
|
United States
|
|
348
|
 RPG Life Sciences
RPGLIFE.NS
|
$0.43 B | $25.78 |
0.00%
|
36.7%
|
India
|
|
349
|
 MeiraGTx
MGTX
|
$0.43 B | $5.41 |
0.00%
|
31.0%
|
United States
|
|
350
|
 Stoke Therapeutics
STOK
|
$0.42 B | $7.69 |
0.00%
|
-14.8%
|
United States
|
|
351
|
 Tourmaline Bio
TRML
|
$0.41 B | $16.01 |
0.00%
|
-9.9%
|
United States
|
|
352
|
 Precigen
PGEN
|
$0.41 B | $1.39 |
0.00%
|
33.8%
|
United States
|
|
353
|
 Verve Therapeutics
VERV
|
$0.41 B | $4.59 |
0.00%
|
20.2%
|
United States
|
|
354
|
 Abivax
ABVX
|
$0.41 B | $6.40 |
0.00%
|
-58.3%
|
France
|
|
355
|
 PureTech Health
PRTC
|
$0.40 B | $16.74 |
0.00%
|
-29.8%
|
United States
|
|
356
|
 Omeros Corporation
OMER
|
$0.39 B | $6.78 |
0.00%
|
183.3%
|
United States
|
|
357
|
 Absci
ABSI
|
$0.39 B | $3.09 |
0.00%
|
-9.2%
|
United States
|
|
358
|
 EyePoint Pharmaceuticals
EYPT
|
$0.39 B | $5.68 |
0.00%
|
-64.5%
|
United States
|
|
359
|
 Zevra Therapeutics
ZVRA
|
$0.39 B | $7.15 |
0.00%
|
66.6%
|
United States
|
|
360
|
 Kamada
KMDA
|
$0.38 B | $6.50 |
0.00%
|
54.3%
|
Israel
|
|
361
|
 Aarti Drugs
AARTIDRUGS.NS
|
$0.38 B | $4.19 |
0.00%
|
-14.9%
|
India
|
|
362
|
 Revance Therapeutics
RVNC
|
$0.38 B | $3.65 |
0.00%
|
-3.4%
|
United States
|
|
363
|
 Autolus Therapeutics
AUTL
|
$0.38 B | $1.43 |
0.00%
|
-46.7%
|
United Kingdom
|
|
364
|
 Regencell Bioscience
RGC
|
$0.38 B | $29.12 |
0.00%
|
-32.4%
|
Hong Kong
|
|
365
|
 G1 Therapeutics
GTHX
|
$0.38 B | $7.15 |
0.00%
|
74.0%
|
United States
|
|
366
|
 Sana Biotechnology
SANA
|
$0.37 B | $1.65 |
0.00%
|
-64.1%
|
United States
|
|
367
|
 Rapport Therapeutics
RAPP
|
$0.37 B | $10.15 |
0.00%
|
-21.0%
|
United States
|
|
368
|
 Mereo BioPharma Group
MREO
|
$0.37 B | $2.30 |
0.00%
|
42.4%
|
United Kingdom
|
|
369
|
 Amylyx Pharmaceuticals
AMLX
|
$0.35 B | $3.98 |
0.00%
|
100.0%
|
United States
|
|
370
|
 Benitec Biopharma
BNTC
|
$0.35 B | $13.75 |
0.00%
|
55.7%
|
United States
|
|
371
|
 Altimmune
ALT
|
$0.35 B | $4.55 |
0.00%
|
-4.3%
|
United States
|
|
372
|
 Pacific Biosciences
PACB
|
$0.35 B | $1.17 |
0.00%
|
-14.2%
|
United States
|
|
373
|
 Medios AG
ILM1.DE
|
$0.34 B | $13.31 |
0.00%
|
-3.0%
|
Germany
|
|
374
|
 Amplitude Surgical SA
AMPLI.PA
|
$0.33 B | $6.89 |
0.00%
|
11.1%
|
France
|
|
375
|
 Erasca
ERAS
|
$0.33 B | $1.16 |
0.00%
|
-8.4%
|
United States
|
|
376
|
 Inventiva
IVA
|
$0.32 B | $3.36 |
0.00%
|
-30.9%
|
France
|
|
377
|
 Tectonic Therapeutic
TECX
|
$0.32 B | $17.02 |
0.00%
|
141.5%
|
United States
|
|
378
|
 Allogene Therapeutics
ALLO
|
$0.32 B | $1.45 |
0.00%
|
-57.3%
|
United States
|
|
379
|
 Idorsia
IDIA.SW
|
$0.31 B | $1.40 |
0.00%
|
-59.1%
|
Switzerland
|
|
380
|
 Entrada Therapeutics
TRDA
|
$0.31 B | $8.13 |
0.00%
|
5.8%
|
United States
|
|
381
|
 Olema Pharmaceuticals
OLMA
|
$0.30 B | $4.42 |
0.00%
|
-48.0%
|
United States
|
|
382
|
 Alimera Sciences
ALIM
|
$0.30 B | $5.54 |
0.00%
|
65.9%
|
United States
|
|
383
|
 Rigel Pharmaceuticals
RIGL
|
$0.30 B | $16.85 |
0.00%
|
98.7%
|
United States
|
|
384
|
 REGENXBIO
RGNX
|
$0.30 B | $5.94 |
0.00%
|
-49.7%
|
United States
|
|
385
|
 Verastem Oncology
VSTM
|
$0.30 B | $5.74 |
0.00%
|
-42.1%
|
United States
|
|
386
|
 Atai Life Sciences
ATAI
|
$0.29 B | $1.47 |
0.00%
|
24.3%
|
Germany
|
|
387
|
 Arcturus Therapeutics
ARCT
|
$0.29 B | $10.53 |
0.00%
|
-38.0%
|
United States
|
|
388
|
 Personalis
PSNL
|
$0.28 B | $3.19 |
0.00%
|
288.4%
|
United States
|
|
389
|
 Phathom Pharmaceuticals
PHAT
|
$0.28 B | $4.03 |
0.00%
|
-39.7%
|
United States
|
|
390
|
 Heron Therapeutics
HRTX
|
$0.28 B | $1.84 |
0.00%
|
-37.1%
|
United States
|
|
391
|
 Monte Rosa Therapeutics
GLUE
|
$0.28 B | $4.55 |
0.00%
|
10.3%
|
United States
|
|
392
|
 MaxCyte
MXCT
|
$0.28 B | $2.61 |
0.00%
|
10.4%
|
United States
|
|
393
|
 Eurobio Scientific
ALERS.PA
|
$0.28 B | $27.64 |
0.00%
|
70.9%
|
France
|
|
394
|
 aTyr Pharma
ATYR
|
$0.28 B | $3.10 |
0.00%
|
135.6%
|
United States
|
|
395
|
 Alumis
ALMS
|
$0.27 B | $5.00 |
0.00%
|
-63.8%
|
United States
|
|
396
|
 Cartesian Therapeutics
RNAC
|
$0.27 B | $10.50 |
0.00%
|
3.4%
|
United States
|
|
397
|
 Aura Biosciences
AURA
|
$0.27 B | $5.36 |
0.00%
|
7.9%
|
United States
|
|
398
|
 Euroapi
EAPI.PA
|
$0.27 B | $2.82 |
0.00%
|
12.7%
|
France
|
|
399
|
 Shinpoong Pharm
019170.KS
|
$0.26 B | $5.32 |
0.00%
|
-33.9%
|
South Korea
|
|
400
|
 Sanara MedTech
SMTI
|
$0.26 B | $29.43 |
0.00%
|
3.3%
|
United States
|